| EZH2 mutations are frequent and represent an early event in follicular lymphoma C Bödör, V Grossmann, N Popov, J Okosun, C O’Riain, K Tan, J Marzec, ... Blood, The Journal of the American Society of Hematology 122 (18), 3165-3168, 2013 | 353 | 2013 |
| Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients M Marschalkó, N Erős, O Kontár, B Hidvégi, J Telek, J Hársing, H Jókai, ... Journal of the European Academy of Dermatology and Venereology 29 (5), 964-972, 2015 | 45 | 2015 |
| Molecular subtypes and genomic profile of primary central nervous system lymphoma C Bödör, D Alpár, D Marosvári, B Galik, H Rajnai, B Bátai, Á Nagy, ... Journal of Neuropathology & Experimental Neurology 79 (2), 176-183, 2020 | 42 | 2020 |
| GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas Z Hujber, G Horváth, G Petővári, I Krencz, T Dankó, K Mészáros, H Rajnai, ... Journal of Experimental & Clinical Cancer Research 37, 1-12, 2018 | 33 | 2018 |
| Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma H Rajnai, C Bödör, Z Balogh, É Gagyi, J Csomor, T Krenács, E Tóth, ... Histopathology 60 (6B), E66-E75, 2012 | 28 | 2012 |
| The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone H Rajnai, FH Heyning, L Koens, A Sebestyén, H Andrikovics, ... Virchows Archiv 464, 229-239, 2014 | 27 | 2014 |
| Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone P Balla, L Moskovszky, Z Sapi, R Forsyth, H Knowles, NA Athanasou, ... Histopathology 59 (3), 376-389, 2011 | 27 | 2011 |
| Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells G Petővári, Z Hujber, I Krencz, T Dankó, N Nagy, F Tóth, R Raffay, ... Cancer Cell International 18, 1-17, 2018 | 23 | 2018 |
| High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia Z Balogh, L Reiniger, H Rajnai, J Csomor, Á Szepesi, A Balogh, L Deák, ... Leukemia & lymphoma 52 (6), 1080-1084, 2011 | 23 | 2011 |
| Inhibition of metabolic shift can decrease therapy resistance in human high-grade glioma cells G Petővári, T Dankó, I Krencz, Z Hujber, H Rajnai, E Vetlényi, R Raffay, ... Pathology & Oncology Research 26, 23-33, 2020 | 22 | 2020 |
| Case of the month 1-2019: CNS high-grade neuroepithelial tumor with BCOR alteration C Haberler, L Reiniger, H Rajnai, O Kalev, E Gelpi, M Tamesberger, ... Clinical Neuropathology 38 (1), 4, 2019 | 15 | 2019 |
| Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt E Sári, ZG Nagy, K Baghy, H Rajnai, C Bödör, J Csomor, G Barna, ... Pathology & Oncology Research 20, 973-980, 2014 | 13 | 2014 |
| DNA and RNA isolated from tissues processed by microwave-accelerated apparatus MFX-800-3 are suitable for subsequent PCR and Q-RT-PCR amplification C Bödör, O Schmidt, B Csernus, H Rajnai, B Szende Pathology & Oncology Research 13, 149-152, 2007 | 12 | 2007 |
| Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas H Rajnai, I Teleki, G Kiszner, N Meggyesházi, P Balla, T Vancsik, ... Journal of Immunology Research 2015, 2015 | 11 | 2015 |
| Germline MUTYH mutations and high‐grade gliomas: Novel evidence for a potential association G Bedics, L Kotmayer, E Zajta, LL Hegyi, EÁ Brückner, H Rajnai, ... Genes, Chromosomes and Cancer 61 (10), 622-628, 2022 | 10 | 2022 |
| EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes K Szurián, I Csala, D Marosvári, H Rajnai, K Dezső, C Bödör, V Piurkó, ... Experimental and Molecular Pathology 105 (2), 161-165, 2018 | 8 | 2018 |
| Demethylation status of somatic DNA extracted from pituitary neuroendocrine tumors indicates proliferative behavior B Szabó, K Németh, K Mészáros, N Szücs, S Czirják, L Reiniger, H Rajnai, ... The Journal of Clinical Endocrinology & Metabolism 105 (6), 2015-2026, 2020 | 7 | 2020 |
| Distinct miRNA expression signatures of primary and secondary central nervous system lymphomas E Sebestyén, Á Nagy, D Marosvári, H Rajnai, B Kajtár, B Deák, ... The Journal of Molecular Diagnostics 24 (3), 224-240, 2022 | 5 | 2022 |
| Immunohistochemical detection of the presence of vitamin D receptor in childhood solid tumors O Juhász, N Jákob, H Rajnai, M Imrei, M Garami Cancers 14 (14), 3295, 2022 | 4 | 2022 |
| Histopathological difficulties in an adolescent lymphoma patient F Magyari, S Barna, Z Miltényi, H Rajnai, J Csomor, M Udvardy, Á Illés, ... Pathology & Oncology Research 21, 213-217, 2015 | 4 | 2015 |
